Remarkably, it has become evident that presence of autoantibodies to citrullinated proteins (ACPA) distinguishes two clinically relevant subgroups of RA: ACPA-positive and ACPA-negative. The gene discussed is PRTN3; the disease is rheumatoid arthritis.